Inhibitor Therapeutics, Inc.
INTI
$0.08
$0.0110.26%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -20.20% | -20.36% | -13.51% | -22.92% | -12.09% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -18.19% | -5.00% | -7.16% | 12.87% | 20.11% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -20.14% | -20.00% | -13.37% | -22.37% | -11.73% |
|
|
|||||
| Total Current Assets | -20.14% | -20.00% | -13.37% | -22.37% | -11.73% |
| Net Property, Plant & Equipment | -9.56% | -8.49% | -7.83% | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -19.90% | -19.77% | -13.26% | -20.89% | -11.73% |
|
|
|||||
| Total Accounts Payable | 162.76% | -81.54% | 189.37% | 130.82% | 835.29% |
| Total Accrued Expenses | 1,608.17% | 424.68% | -75.94% | -95.39% | 1,517.02% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -10.18% | 5.77% | 0.00% | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 775.77% | -37.50% | 47.84% | -86.65% | 1,491.03% |
|
|
|||||
| Total Current Liabilities | 775.77% | -37.50% | 47.84% | -86.65% | 1,491.03% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -16.52% | -15.16% | -10.79% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Liabilities | 21.44% | -1.89% | 1.23% | -15.00% | 21.84% |
|
|
|||||
| Common Stock & APIC | 0.00% | 0.00% | 0.04% | 0.00% | 0.00% |
| Retained Earnings | -2.39% | -1.33% | -1.25% | -1.21% | -2.80% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -37,011.43% | -99.51% | -47.08% | -31.88% | -41.74% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -37,011.43% | -99.51% | -47.08% | -31.88% | -41.74% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -37,011.43% | -99.51% | -47.08% | -31.88% | -41.74% |
|
|
|||||